DeepSeek AI Model Garners Silicon Valley Praise Highlights Chinas Chip Workaround Capabilities Gold Price Forecast 2026 Analysts Eye Potential Rally Amid Economic Uncertainty Walmarts Cautious Sales Outlook Rattles Investor Sentiment AnheuserBusch InBev Shares Decline as Revenue Falls Short of Analyst Expectations SpaceX Confidential IPO Filing Paves Way for Potential Stock Market Debut Under Ticker SPCX Tech Innovations Reshaping Healthcare A New Era of Digital Medicine PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline BitGo Holdings Inc BTGO Q1 2026 Earnings Significant Earnings Miss Sparks Sharp Stock Decline FFWM Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Movement TLF Q1 2026 Earnings Modest Profitability Amid Quiet Quarter Smurfit WestRock Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Retractable Technologies Q3 2023 Earnings Loss Per Share of 014 Reported Stock Rises Amid Limited Disclosure Select Medical Holdings SEM Holds Steady Near Key Support After Modest Uptick NIO Inc Shares Slide 7 as Bearish Momentum Tests Key Support at 494 Great Elm Group Notes GEGGL Steady at 2454 as FixedIncome Investors Seek Yield Loar Holdings LOAR Holds Steady Near Support Amid Low Volatility Trading CompX International CIX Advances 27 as Stock Tests Resistance at 2513 Blackstone Mortgage Trust BXMT Q1 2026 Earnings EPS Falls Short Amid Challenging Credit Environment SBFM Q1 2026 Earnings PreRevenue Biotech Reports Net Loss of 025 Per Share Stock Falls 25 Rand Capital Corporation RAND Q1 2026 Earnings Net Investment Income Generated Amidst Portfolio Adjustments Rollins Inc ROL Q1 2026 Earnings EPS Edges Past Estimates Shares Dip Slightly Waldencast WALD Q4 2024 Earnings Significant EPS Miss Reflects Persistent Operational Challenges Village Farms International VFF Q1 2026 Earnings EPS Misses Estimates Slightly Amid Undisclosed Revenue Trumps Decision to Skip Sons Bahamas Wedding Highlights Ongoing Iran Tensions COTY Q1 2026 Earnings EPS Misses Estimates by Wide Margin Revenue Data Unavailable Sagimet Biosciences SGMT Gains 129 as Shares Test Key Resistance Level